Page last updated: 2024-08-22

apazone and allopurinol

apazone has been researched along with allopurinol in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19906 (75.00)18.7374
1990's0 (0.00)18.2507
2000's2 (25.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lombardo, F; Obach, RS; Waters, NJ1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Braven, J; Hardwell, TR; Hickling, P; Whittaker, M1
Davis, RH; Fraser, RC; Walker, FS1
Jahn, U; Thiele, K1
Mackin, WM; Montor, SG; Thoolen, MJ; Timmermans, PB1
Armstrong, RD; Fairbanks, LD; Gibson, T; Rodgers, AV; Simmonds, HA1
Templeton, JS1

Trials

2 trial(s) available for apazone and allopurinol

ArticleYear
Comparative trial of azapropazone and indomethacin plus allopurinol in acute gout and hyperuricaemia.
    The Journal of the Royal College of General Practitioners, 1987, Volume: 37, Issue:302

    Topics: Adult; Aged; Allopurinol; Apazone; Clinical Trials as Topic; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Female; Gout; Humans; Indomethacin; Male; Middle Aged; Random Allocation; Triazines; Uric Acid

1987
Azapropazone or allopurinol in the treatment of chronic gout and/or hyperuricaemia. A preliminary report.
    The British journal of clinical practice, 1982, Volume: 36, Issue:10

    Topics: Adult; Aged; Allopurinol; Apazone; Female; Gout; Humans; Kidney Function Tests; Male; Middle Aged; Triazines; Uric Acid

1982

Other Studies

6 other study(ies) available for apazone and allopurinol

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Effect of treatment on erythrocyte phosphoribosyl pyrophosphate synthetase and glutathione reductase activity in patients with primary gout.
    Annals of the rheumatic diseases, 1986, Volume: 45, Issue:11

    Topics: Adult; Aged; Allopurinol; Apazone; Enzyme Activation; Erythrocytes; Glutathione Reductase; Gout; Humans; Male; Middle Aged; Phosphotransferases; Ribose-Phosphate Pyrophosphokinase; Triazines

1986
In vitro inhibition of xanthine oxidase by azapropazone and 8-hydroxy-azapropazone.
    Arzneimittel-Forschung, 1988, Volume: 38, Issue:4

    Topics: Allopurinol; Anti-Inflammatory Agents, Non-Steroidal; Apazone; In Vitro Techniques; Spectrophotometry, Ultraviolet; Triazines; Xanthine Oxidase

1988
Effect of azapropazone and allopurinol on myocardial infarct size in rats.
    European journal of pharmacology, 1987, Aug-11, Volume: 140, Issue:2

    Topics: Allopurinol; Animals; Apazone; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Triazines

1987
Azapropazone--a treatment for hyperuricaemia and gout?
    British journal of rheumatology, 1984, Volume: 23, Issue:1

    Topics: Adult; Aged; Allopurinol; Apazone; Creatinine; Gout; Humans; Middle Aged; Osmolar Concentration; Triazines; Uric Acid; Urination

1984